Hemato-oncology
Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation
Seung-Shin Lee, Jae-Sook Ahn, Sung-Hoon Jung, Seo-Yeon Ahn, Jae-Yong Kim, Hee-Chang Jang, Seung-Ji Kang, Mi-Ok Jang, Deok-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Hyeoung-Joon Kim
Korean J Intern Med. 2015;30(2):212-218. Published online February 27, 2015
Background/Aims: BK virus (BKV) has been associated with late-onset hemorrhagic cystitis (HC) in recipients of hematopoietic stem cell transplantation (HSCT). Cidofovir has been used at higher doses ( 3 to 5 mg/kg/wk) with probenecid prophylaxis; however, cidofovir may result in nephrotoxicity or cy..
|